2014 annual financial data
Rigel Pharmaceuticals 2014 Operating margin
Direct answer
Operating margin was -1,106.05%.
Operating income was -91,249,000 USD and net income was -90,908,000 USD.
Operating cash flow was -69,753,000 USD.
Get free Rigel Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 8,250,000 USD
- Operating income
- -91,249,000 USD
- Net income
- -90,908,000 USD
- Operating cash flow
- -69,753,000 USD